These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 38877777

  • 1. Intravascular Lithotripsy for Treatment of Severely Calcified Common Femoral Artery Disease: Results From the Disrupt PAD III Observational Study.
    Shammas NW, Mangalmurti S, Bernardo NL, Mehrle A, Adams G, Bertolet B, Stavroulakis K, Soukas PA.
    J Endovasc Ther; 2024 Jun 15; ():15266028241255622. PubMed ID: 38877777
    [Abstract] [Full Text] [Related]

  • 2. Intravascular Lithotripsy for Treatment of Calcified Infrapopliteal Lesions: Results from the Disrupt PAD III Observational Study.
    Adams G, Soukas PA, Mehrle A, Bertolet B, Armstrong EJ.
    J Endovasc Ther; 2022 Feb 15; 29(1):76-83. PubMed ID: 34380334
    [Abstract] [Full Text] [Related]

  • 3. Intravascular Lithotripsy for Treatment of Calcified Lower Extremity Arterial Stenosis: Initial Analysis of the Disrupt PAD III Study.
    Adams G, Shammas N, Mangalmurti S, Bernardo NL, Miller WE, Soukas PA, Parikh SA, Armstrong EJ, Tepe G, Lansky A, Gray WA.
    J Endovasc Ther; 2020 Jun 15; 27(3):473-480. PubMed ID: 32242768
    [Abstract] [Full Text] [Related]

  • 4. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Disrupt PAD III Observational Study.
    Armstrong EJ, Adams G, Soukas PA, Mangalmurti SS, Shammas NW, Mehrle A, Bertolet B, Gray WA, Tepe G, Woo EY, McKinsey JF, Holden A, Parikh SA.
    J Endovasc Ther; 2024 Oct 18; ():15266028241283716. PubMed ID: 39422234
    [Abstract] [Full Text] [Related]

  • 5. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial.
    Tepe G, Brodmann M, Werner M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, Nolte-Ernsting C, Bertolet B, Scheinert D, Gray WA, Disrupt PAD III Investigators.
    JACC Cardiovasc Interv; 2021 Jun 28; 14(12):1352-1361. PubMed ID: 34167675
    [Abstract] [Full Text] [Related]

  • 6. Intravascular Lithotripsy for Treatment of Calcified, Stenotic Iliac Arteries: A Cohort Analysis From the Disrupt PAD III Study.
    Armstrong EJ, Soukas PA, Shammas N, Chamberlain J, Pop A, Adams G, de Freitas D, Valle J, Woo E, Bernardo NL.
    Cardiovasc Revasc Med; 2020 Oct 28; 21(10):1262-1268. PubMed ID: 32147133
    [Abstract] [Full Text] [Related]

  • 7. Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Severely Calcified Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K, Torsello G, Chlouverakis G, Bisdas T, Damerau S, Tsilimparis N, Argyriou A.
    J Endovasc Ther; 2024 Dec 28; 31(6):1165-1172. PubMed ID: 36896876
    [Abstract] [Full Text] [Related]

  • 8. Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study.
    Nagpal S, Altin SE, McGinigle K, Mangalmurti SS, Adams G, Shammas NW, Mehrle A, Soukas P, Bertolet B, Lansky AJ.
    J Vasc Surg; 2024 Feb 28; 79(2):358-365. PubMed ID: 37925039
    [Abstract] [Full Text] [Related]

  • 9. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
    Radaideh Q, Shammas NW, Shammas WJ, Shammas GA.
    Cardiovasc Revasc Med; 2021 Jan 28; 22():66-70. PubMed ID: 32563711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses.
    Brodmann M, Schwindt A, Argyriou A, Gammon R.
    J Endovasc Ther; 2019 Jun 28; 26(3):283-287. PubMed ID: 31006305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of severely calcified coronary artery disease by intravascular lithotripsy primary outcomes and 180-day follow-up from the Chinese SOLSTICE Trial.
    Tian F, Zhou SS, Liu JH, Chen H, Sun ZJ, Chen L, Wang Q, Jing J, Chen YD.
    J Geriatr Cardiol; 2023 Jan 28; 20(1):32-39. PubMed ID: 36875163
    [Abstract] [Full Text] [Related]

  • 17. Treatment of severe coronary artery calcification with intravascular lithotripsy: Initial experience of a prospective single centre registry.
    Yap LB, Choy CN, Navin S, Koh KW, Jeyamalar R, Balachandran K.
    Med J Malaysia; 2022 Jul 28; 77(4):500-505. PubMed ID: 35902942
    [Abstract] [Full Text] [Related]

  • 18. Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions: Patient-Level Pooled Analysis of the Disrupt CAD Studies.
    Kereiakes DJ, Di Mario C, Riley RF, Fajadet J, Shlofmitz RA, Saito S, Ali ZA, Klein AJ, Price MJ, Hill JM, Stone GW.
    JACC Cardiovasc Interv; 2021 Jun 28; 14(12):1337-1348. PubMed ID: 33939604
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient-level pooled data analysis.
    Madhavan MV, Shahim B, Mena-Hurtado C, Garcia L, Crowley A, Parikh SA.
    Catheter Cardiovasc Interv; 2020 Apr 01; 95(5):959-968. PubMed ID: 31957955
    [Abstract] [Full Text] [Related]

  • 20. Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study.
    Ali ZA, Nef H, Escaned J, Werner N, Banning AP, Hill JM, De Bruyne B, Montorfano M, Lefevre T, Stone GW, Crowley A, Matsumura M, Maehara A, Lansky AJ, Fajadet J, Di Mario C.
    Circ Cardiovasc Interv; 2019 Oct 01; 12(10):e008434. PubMed ID: 31553205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.